These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 11939298

  • 41. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
    Yongyuth P, Koyadun S, Jaturabundit N, Sampuch A, Bhumiratana A.
    J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
    [Abstract] [Full Text] [Related]

  • 42. Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.
    Kazura J, Greenberg J, Perry R, Weil G, Day K, Alpers M.
    Am J Trop Med Hyg; 1993 Dec; 49(6):804-11. PubMed ID: 8279647
    [Abstract] [Full Text] [Related]

  • 43. Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India.
    Yuvaraj J, Pani SP, Vanamail P, Ramaiah KD, Das PK.
    Trop Med Int Health; 2008 May; 13(5):737-42. PubMed ID: 18346027
    [Abstract] [Full Text] [Related]

  • 44. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
    da Silva JSF, Braga C, Duarte FM, Oliveira P, Feitosa Luna C, Marcondes M, Araújo J, Grilis MR, de Souza Melo PFA, Brandão E, Rocha A.
    Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
    [Abstract] [Full Text] [Related]

  • 45. Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation.
    Cartel JL, Spiegel A, Nguyen Ngnoc L, Cardines R, Plichart R, Martin PM, Roux JF, Moulia-Pelat JP.
    Trop Med Parasitol; 1992 Jun; 43(2):91-4. PubMed ID: 1519031
    [Abstract] [Full Text] [Related]

  • 46. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia.
    Addiss DG, Eberhard ML, Lammie PJ, McNeeley MB, Lee SH, McNeeley DF, Spencer HC.
    Am J Trop Med Hyg; 1993 Feb; 48(2):178-85. PubMed ID: 8447520
    [Abstract] [Full Text] [Related]

  • 47. Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis.
    Moulia-Pelat JP, Glaziou P, Weil GJ, Nguyen LN, Gaxotte P, Nicolas L.
    Trop Med Parasitol; 1995 Mar; 46(1):9-12. PubMed ID: 7631132
    [Abstract] [Full Text] [Related]

  • 48. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.
    Ismail MM, Weil GJ, Jayasinghe KS, Premaratne UN, Abeyewickreme W, Rajaratnam HN, Sheriff MH, Perera CS, Dissanaike AS.
    Trans R Soc Trop Med Hyg; 1996 Mar; 90(6):684-8. PubMed ID: 9015519
    [Abstract] [Full Text] [Related]

  • 49. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
    Ramaiah KD, Vanamail P, Yuvaraj J, Das PK.
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901
    [Abstract] [Full Text] [Related]

  • 50. Advantages of an annual single dose of ivermectin 400 micrograms/kg plus diethylcarbamazine for community treatment of bancroftian filariasis.
    Moulia-Pelat JP, Nguyen LN, Hascoët H, Luquiaud P, Nicolas L.
    Trans R Soc Trop Med Hyg; 1995 Aug; 89(6):682-5. PubMed ID: 8594696
    [Abstract] [Full Text] [Related]

  • 51. Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
    Laman M, Tavul L, Karl S, Kotty B, Kerry Z, Kumai S, Samuel A, Lorry L, Timinao L, Howard SC, Makita L, John L, Bieb S, Wangi J, Albert JM, Payne M, Weil GJ, Tisch DJ, Bjerum CM, Robinson LJ, King CL.
    Lancet Infect Dis; 2022 Aug; 22(8):1200-1209. PubMed ID: 35533701
    [Abstract] [Full Text] [Related]

  • 52. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
    de Kraker ME, Stolk WA, van Oortmarssen GJ, Habbema JD.
    Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
    [Abstract] [Full Text] [Related]

  • 53. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
    Ottesen EA, Vijayasekaran V, Kumaraswami V, Perumal Pillai SV, Sadanandam A, Frederick S, Prabhakar R, Tripathy SP.
    N Engl J Med; 1990 Apr 19; 322(16):1113-7. PubMed ID: 2181312
    [Abstract] [Full Text] [Related]

  • 54. Double blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months.
    Cartel JL, Spiegel A, Nguyen L, Genelle B, Roux JF.
    Trop Med Parasitol; 1991 Mar 19; 42(1):38-40. PubMed ID: 2052854
    [Abstract] [Full Text] [Related]

  • 55. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP, Kalimuthu M, Rajendran R, Munirathinam A, Ashok Kumar V, Nagaraj J, Tyagi BK.
    Parasitol Int; 2015 Feb 19; 64(1):1-4. PubMed ID: 25205435
    [Abstract] [Full Text] [Related]

  • 56. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
    Kura K, Stolk WA, Basáñez MG, Collyer BS, de Vlas SJ, Diggle PJ, Gass K, Graham M, Hollingsworth TD, King JD, Krentel A, Anderson RM, Coffeng LE.
    Clin Infect Dis; 2024 Apr 25; 78(Supplement_2):S93-S100. PubMed ID: 38662701
    [Abstract] [Full Text] [Related]

  • 57. Influence of anti-filarial chemotherapy strategies on the genetic structure of Wuchereria bancrofti populations.
    Ramasamy D, Laxmanappa HS, Sharma R, Das MK.
    Mem Inst Oswaldo Cruz; 2011 Mar 25; 106(2):240-7. PubMed ID: 21537687
    [Abstract] [Full Text] [Related]

  • 58. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
    Supali T, Ismid IS, Rückert P, Fischer P.
    Trop Med Int Health; 2002 Oct 25; 7(10):894-901. PubMed ID: 12358626
    [Abstract] [Full Text] [Related]

  • 59. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
    Edi C, Bjerum CM, Ouattara AF, Chhonker YS, Penali LK, Méité A, Koudou BG, Weil GJ, King CL, Murry DJ.
    PLoS Negl Trop Dis; 2019 May 25; 13(5):e0007325. PubMed ID: 31107869
    [Abstract] [Full Text] [Related]

  • 60. [Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine: immunological observation].
    Zheng HJ, Tao ZH, Cheng WF, Wang SH, Cheng SZ, Ye YM, Luo LF, Chen XR, Gan GB, Piessens WF.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993 May 25; 11(1):33-7. PubMed ID: 8403274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.